Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sih-Tong Chen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of Visualized Experiments : Jove|January 19, 2026
Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T FluorescenceShao-I Chin, Zi-Min Zeng, Sih-Tong Chen, et al.
Journal of Personalized Medicine|December 23, 2022
Novel Potential Therapeutic Targets of PTPN Families for Lung CancerChin-Chou Wang, Wan-Jou Shen, Gangga Anuraga, et al.
Frontiers in Bioscience (Landmark Edition)|January 8, 2026
SB431542, a Selective Inhibitor of the TGF-β Type I Receptor, Enhances Doxorubicin Antitumor Activity via p63 Activation in Mutant p53 Breast Cancer CellsYu-Ling Kou, Yu-Jie Liu, Tzu-Chi Hsu, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of Visualized Experiments : Jove|January 19, 2026
Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T FluorescenceShao-I Chin, Zi-Min Zeng, Sih-Tong Chen, et al.
Journal of Personalized Medicine|December 23, 2022
Novel Potential Therapeutic Targets of PTPN Families for Lung CancerChin-Chou Wang, Wan-Jou Shen, Gangga Anuraga, et al.
Frontiers in Bioscience (Landmark Edition)|January 8, 2026
SB431542, a Selective Inhibitor of the TGF-β Type I Receptor, Enhances Doxorubicin Antitumor Activity via p63 Activation in Mutant p53 Breast Cancer CellsYu-Ling Kou, Yu-Jie Liu, Tzu-Chi Hsu, et al.
Pageof 1